Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Clin Oncol. Oct 10, 2014; 5(4): 677-692
Published online Oct 10, 2014. doi: 10.5306/wjco.v5.i4.677
Table 1 Breast cancer and cyclooxygenase-2 blocking agents: Results of a case control study[79]
AgentOR (95%CI)
COX-2 inhibitor0.29 (0.14-0.59)
Ibuprofen0.37 (0.18-0.72)
Regular aspirin (325 mg)0.51 (0.27-0.98)
Low dose aspirin (81 mg)0.77 (0.41-1.41)
Acetaminophen1.02 (0.39-2.20)
Selective COX-2 inhibitors: Celecoxib or Rofecoxib